Home > Insider Trading > Filing (0001104659-24-048025)

Filing Details

Accession Number:: 0001104659-24-048025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-04-17 06:08:36
Reporting Period:: 2024-03-26

Accepted Time:: 2024-04-17 06:08:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1851182	Future Health Esg Corp.	FHLT	Blank Checks (6770)	862305680

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1854105	Future Health Esg Associates 1, Llc	C/O Future Health Esg Corp. 8 The Green, Suite #12081 Dover DE 19901		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2024-03-26	1,703,486	$0.00	921,514	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

On March 26, 2024, pursuant to that certain Purchase and Sponsor Handover Agreement entered into on February 23, 2024 (as amended to date, the "Purchase and Sponsor Handover Agreement") by and among Future Health ESG Corp. (the "Issuer"), Future Health ESG Associates 1, LLC (the "Sponsor") and Blufire Capital Limited (the "New Sponsor"), the Sponsor transferred 1,698,486 shares of common stock, par value $0.0001 per share, of the Issuer ("Common Stock") to the New Sponsor in connection with the transactions contemplated by the Purchase and Sponsor Handover Agreement (together, the "Sponsor Handover"), pursuant to which
(i) the Sponsor and certain insiders and anchor investors of the Issuer transferred and assigned 3,020,202 shares of Common Stock and 3,875,000 warrants to purchase shares of Common Stock in exchange for the New Sponsor assuming certain liabilities in an aggregate amount of approximately $500,000 of the Issuer and the Sponsor, including all ongoing expenses associated with and expected for the consummation of an initial business combination, costs and expenses incurred by the Issuer in the ordinary course of business or in connection with the transactions contemplated by the Purchase and Sponsor Handover Agreement, and $250,000 in cash payable upon the execution of a letter of intent to enter into a business combination by the Issuer with a potential target, and
(ii) the New Sponsor became the sponsor of the Issuer, as more fully described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 27, 2024. In connection with the Sponsor Handover, the Sponsor also transferred 5,000 founder shares to an advisory and strategic communications firm as payment for certain investor relations and advisory services.